iPS dendritic cell vaccine effective against cancer in digestive organs – Wakayama Medical University
At Wakayama Medical University, a research group including Professor Hiroki Yamaue and Associate Professor Toshiyasu Ojima has confirmed that dendritic cells derived from iPS cells have a vaccination effect against solid tumors in digestive organs. The researchers obtained dendritic cells from iPS cells derived from the skin fibroblasts of healthy people. They then introduced a carcinoembryonic antigen that is a tumor marker expressed in solid tumors in digestive organs and is also an antigen gene, to create an iPS-DC vaccine containing tumor information. In in vitro tests, the researchers planted iPS-DC in CEA-expressing tumor cells, and confirmed that it attacked the tumor cells through T lymphocytes. In genetically modified mice, a strong anti-tumor effect was similarly observed using subcutaneous tumor models derived from colon cancer cells. Such an effect was found in tumors in digestive organs, as well as melanomas, for which the effect had already been confirmed.
Science News List
- Mar 27, 2018DIC develops non-stick dish to collect cultured cells without damaging them
- Mar 21, 2018KHI develops automated system for low-cost cell culturing
- Mar 01, 2018University of Tokyo determines how protein protects genetic information – paves way for infertility treatment and pharmaceutical development
- Jan 31, 2018Looking into the birth of galaxies – World-class optical/infrared telescope completed by the Institute of Astronomy, University of Tokyo
- Jan 22, 2018JAXA to test takeoff, landing, and flight of reusable rocket